NCT03981822Phase 2Completed

A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts

Study sponsor: Verrica Pharmaceuticals Inc. · VRCA

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2020-05-21Actual
Enrollment · participants105Actual
Source updated2024-11-27Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.